----

----

| DELAWARE                                                       | 65-0769296                           |
|----------------------------------------------------------------|--------------------------------------|
| (State or other jurisdiction of Incorporation or organization) | (I.R.S. Employer Identification No.) |
|                                                           |                                 |
| 5601 N. DIXIE HIGHWAY                                          |                                 |
| SUITE 411                                                      |                                 |
| FORT  LAUDERDALE, FLORIDA                            | 33334                                |
| (Address of principal executive offices)                       | (Zip Code)                           |

| Registrant’s telephone number:                           | (954)771-1772                        |
|----------------------------------------------------------------|--------------------------------------|
| Securities registered under Section 12(b) of the Exchange Act: | None                                 |
| Securities registered under Section 12(g) of the Exchange Act: | Class A Common Stock, par value $.01 |

| Large accelerated filer | £ | Accelerated filer                               | £ |
|-------------------------|--------|-------------------------------------------------|--------|
| Non-accelerated filer   | £ | Smaller reporting company   | T      |

----

----

----

----

Le@P

| 10-K - YEAR END REPORT        | PAGE                                                                                                                   |
|-------------------------------|------------------------------------------------------------------------------------------------------------------------|
|                          |                                                                                                                   |   |
| PART I                        |                                                                                                                   |
|                          |                                                                                                                   |   |
| ITEM 1.                       | BUSINESS                                                                                                               | 5 |
|                          |                                                                                                                   |   |
| ITEM 1A.                      | RISK FACTORS                                                                                                           | 5 |
|                          |                                                                                                                   |   |
| ITEM 2.                       | PROPERTIES                                                                                                             | 5 |
|                          |                                                                                                                   |   |
| ITEM 3.                       | LEGAL PROCEEDINGS                                                                                                      | 6 |
|                          |                                                                                                                   |   |
| PART II                       |                                                                                                                   |
|                          |                                                                                                                   |   |
| ITEM 5.                       | MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES | 6 |
|                          |                                                                                                                   |   |
| ITEM 7.                       | MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS                                  | 7 |
|                          |                                                                                                                   |   |
| ITEM 7A.                      | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK                                                             | 9 |
|                          |                                                                                                                   |   |
| ITEM 8.                       | FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA                                                                             | 10 |
|                          |                                                                                                                   |   |
| ITEM 9.                       | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE                                   | 10 |
|                          |                                                                                                                   |   |
| ITEM 9A.                      | CONTROLS AND PROCEDURES                                                                                                | 10 |
|                          |                                                                                                                   |   |
| ITEM 9B.                      | OTHER INFORMATION                                                                                                      |   |
|                          |                                                                                                                   |   |
| PART III                      |                                                                                                                   |
|                          |                                                                                                                   |   |
| ITEM 10.                      | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.                                                                | 11 |
|                          |                                                                                                                   |   |
| ITEM 11.                      | EXECUTIVE COMPENSATION                                                                                                 | 11 |
|                          |                                                                                                                   |   |
| ITEM 12.                      | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS                         | 11 |
|                          |                                                                                                                   |   |
| ITEM 13.                      | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTORS INDEPENDENCE                                             | 11 |
|                          |                                                                                                                   |   |
| ITEM 14.                      | PRINCIPAL ACCOUNTANT FEES AND SERVICES                                                                                 | 11 |
|                          |                                                                                                                   |   |
| PART IV                       |                                                                                                                   |
|                          |                                                                                                                   |   |
| ITEM 15.                      | EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K.                                                      | 11 |
|                          |                                                                                                                   |   |
| SIGNATURES                    |                                                                                                                   |
| EX-31.1 – CERTIFICATION |                                                                                                                   |
| EX-32.1 - CERTIFICATION       |                                                                                                                   |

----

Index

----

Index

|   | ITEM 1. | BUSINESS |
|--------|---------|----------|

|   | ITEM 1A. | RISK FACTORS. |
|--------|----------|---------------|

|   | ITEM 2. | PROPERTIES |
|--------|---------|------------|

----

Index

| ITEM 3. | LEGAL PROCEEDINGS |
|---------|-------------------|

| ITEM 5. | MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES |
|---------|------------------------------------------------------------------------------------------------------------------------|

| PRICE PERIOD   |   | HIGH   |   |   | LOW    |   |
|----------------|--------|--------|--------|--------|--------|--------|
|           |   |   |   |   |   |   |
| 2008           |   |   |   |   |   |   |
| First Quarter  |   | $      | .25    |   |   | $      | .10 |   |
| Second Quarter |   |   | .12    |   |   |   | .11 |   |
| Third Quarter  |   |   | .12    |   |   |   | .06 |   |
| Fourth Quarter |   |   | .10    |   |   |   | .05 |   |
|           |   |   |   |   |   |   |   |   |
| 2009           |   |   |   |   |   |   |   |   |
| First Quarter  |   | $      | .00    |   |   | $      | .00 |   |
| Second Quarter |   |   | .15    |   |   |   | .026 |   |
| Third Quarter  |   |   | .04    |   |   |   | .0352 |   |
| Fourth Quarter |   |   | .04    |   |   |   | .03 |   |

----

Index

| Plan Category                                              |   | Number of securities to be issued upon exercise of outstanding options, warrants and rights |   |   | Weighted average exercise price of outstanding options, warrants and rights |   |   | Number of securities remaining available for future issuance |   |
|------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------|--------|--------|-----------------------------------------------------------------------------|--------|--------|--------------------------------------------------------------|--------|
| Equity compensation plans approved by security holders     |   |                                                                                        | 52,500 |   |                                                                        | $      | 3.00   |                                                         |   |   | 10,047,500 |   |
| Equity compensation plans not approved by security holders |   |                                                                                        | -      |   |                                                                        |   | -      |                                                         |   |   | - |   |
| TOTAL                                                      |   |                                                                                        | 52,500 |   |                                                                        | $      | 3.00   |                                                         |   |   | 10,047,500 |   |

| ITEM 7. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
|---------|---------------------------------------------------------------------------------------------|

----

Index

----

Index

| ITEM 7A. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
|----------|-------------------------------------------------------------|

----

Index

| ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
|---------|---------------------------------------------|

| ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE |
|---------|--------------------------------------------------------------------------------------|

| ITEM 9A(T). | CONTROLS AND PROCEDURES |
|-------------|-------------------------|

| Item 9B. | OTHER INFORMATION |
|----------|-------------------|

----

Index

| ITEM 10. | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. |
|----------|---------------------------------------------------------|

| ITEM 11. | EXECUTIVE COMPENSATION |
|----------|------------------------|

| ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS |
|----------|------------------------------------------------------------------------------------------------|

| ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTORS INDEPENDENCE |
|----------|---------------------------------------------------------------------------|

| ITEM 14. | PRINCIPAL ACCOUNTANT FEES AND SERVICES |
|----------|----------------------------------------|

| ITEM 15. | EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K. |
|----------|-------------------------------------------------------------------|

| (a)(1) | Financial Statements |
|--------|----------------------|

|   | Reference is made to the Index set forth on Page F-1 of this Annual Report on Form 10-K. |
|--------|------------------------------------------------------------------------------------------|

| (a)(2) | Financial Statement Schedules |
|--------|-------------------------------|

| (a)(3) | Exhibits |
|--------|----------|

----

Index

| EXHIBIT | DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                          |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.1   | Certificate of Incorporation of Le@P Technology, Inc., filed March 20, 1997 with the Delaware Secretary of State (incorporated by reference to Appendix B to the Company’s Definitive Proxy Statement for the Annual Meeting of Stockholders, as filed with the Securities Exchange Commission (the “SEC”) April 11, 1997).                                                        |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.2   | Certificate of Ownership and Merger of Seal Holdings Corporation filed with the Delaware Secretary of State on June 13, 1997 (incorporated by reference to Exhibit 3.1.2 to the Company’s Annual Report on Form 10-KSB for the year ended December 31, 2005, as filed with the SEC on March 27, 2006).                                                                                         |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.3   | Certificate of Preferred Stock Designation of Le@P Technology, Inc. filed with the Delaware Secretary of State on March 23, 1999 (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K, as filed with the SEC on April 19, 1999).                                                                                                                              |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.4   | Certificate of Amendment to Certificate of Incorporation of Le@P Technology, Inc. filed June 21, 1999 with the Delaware Secretary of State (incorporated by reference to Exhibit 3.1.3 to the Company’s Annual Report on Form 10-KSB for the year ended December 31, 1999, as filed with the SEC on March 30, 2000).                                                                           |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.5   | Certificate of Designation, Preferences, Rights and Limitations of 10% Cumulative Non-Voting Series B Preferred Stock of Le@P Technology, Inc. filed with the Delaware Secretary of State on November 15, 1999 (incorporated by reference to Exhibit 4 to the Company’s Quarterly Report on Form 10-QSB for the quarter ended September 30, 1999, as filed with the SEC on November 15, 1999). |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.6   | Certificate of Amendment to Certificate of Incorporation of Le@P Technology, Inc. filed July 5, 2000 with the Delaware Secretary of State (incorporated by reference to Exhibit 3 to the Company’s Quarterly Report on Form 10-QSB for the quarter ended June 30, 2000, as filed with the SEC on August 14, 2000).                                                                             |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.2     | Bylaws of Le@P Technology, Inc.(incorporated by reference to Appendix C to the Company’s Proxy Statement for the Annual Meeting of Shareholders of Le@P Fleet, Inc. held May 14, 1997, as filed with the SEC on April 11, 1997).                                                                                                                                                               |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.1    | Funding Arrangement by M. Lee Pearce, M.D. (incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K, as filed with the SEC on October 15, 1999).                                                                                                                                                                                                                 |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.2    | Subscription Agreement dated March 30, 2000 with M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.2 in the Company’s Annual Report on From 10-KSB for the fiscal year ended December 31, 2000, as filed with the SEC on March 30, 2001).                                                                                                                                           |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.3    | 1999 Long Term Incentive Plan (incorporated by reference to Exhibit B to the Company’s Definitive Proxy Statement for its Annual Meeting of Stockholders as filed with the SEC on June 4, 1999).                                                                                                                                                                                               |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.4    | 1998 Incentive Option Plan (incorporated by reference to Exhibit A to the Company’s Definitive Proxy Statement for its Annual Meeting of Stockholders as filed with the SEC on June 8, 1998).                                                                                                                                                                                                  |
|    |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.5    | 1997 Incentive Option Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement for its Annual Meeting of Shareholders as filed with the SEC on April 11, 1997).                                                                                                                                                                                               |

----

Index

| 10.6   | Amended 1996 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company’s Form 10-Q for the quarter ended March 31, 1997 as filed with the SEC on May 15, 1997).                                                                                                                                                                                         |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.7   | Promissory Note dated September 28, 2001, in the principal amount of $712,500, executed by Parkson Property LLC (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K as filed with the SEC on October 18, 2001).                                                                                                                               |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.8   | Promissory Note dated November 5, 2002, in the principal amount of $1,755,710, issued to the M. Lee Pearce 1998 Irrevocable Trust, replacing certain promissory notes issued in 2001 and 2002 (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-QSB for the quarter ended September 30, 2002, as filed with the SEC on November 14, 2002). |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.9   | Promissory Note dated January 30, 2003, in the principal amount of $65,000 issued to the M. Lee Pearce 1998 Irrevocable Trust (incorporated by reference to Exhibit 10.18 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2002 as filed with the SEC on March 31, 2003).                                                                    |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.10  | Promissory Note dated March 14, 2003, in the principal amount of $75,000 issued to the M. Lee Pearce 1998 Irrevocable Trust (incorporated by reference to Exhibit 10.19 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2002, as filed with the SEC on March 31, 2003).                                                                     |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.11  | Promissory Note dated April 23, 2003, in the principal amount of $55,000 issued to the M. Lee Pearce 1998 Irrevocable Trust (incorporated by reference to Exhibit 10.1 in the Company’s Quarterly Report on Form 10-QSB for the quarter ended March 31, 2003, as filed with the SEC on May 15, 2003).                                                                            |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.12  | Written Consent to Action dated May 6, 2003 extending the due date of a note to January 15, 2005 (incorporated by reference to Exhibit 10.2 in the Company’s Quarterly Report on Form 10-QSB for the quarter ended March 31, 2003, as filed with the SEC on May 15, 2003).                                                                                                       |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.13  | Promissory Note dated June 30, 2003, in the principal amount of $71,000 issued to the M. Lee Pearce 1998 Irrevocable Trust (incorporated by reference to Exhibit 10.1 in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003 as filed with the SEC on August 8, 2003).                                                                               |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.14  | Promissory Note dated July 24, 2003, in the principal amount of $80,000 issued to the M. Lee Pearce 1998 Irrevocable Trust (incorporated by reference to Exhibit 10.2 in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003 as filed with the SEC on August 8, 2003).                                                                               |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.15  | Promissory Note dated November 3, 2003, in the principal amount of $37,000 issued to M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.22 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2003, as filed with the SEC on March 22, 2004).                                                                                        |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.16  | Promissory Note dated December 8, 2003, in the principal amount of $30,000 issued to M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.23 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2003, as filed with the SEC on March 22, 2004).                                                                                        |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.17  | Promissory Note dated December 29, 2003, in the principal amount of $25,000 issued to M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.24 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2003, as filed with the SEC on March 22, 2004).                                                                                       |
|   |                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.18  | Promissory Note dated March 11, 2004, in the principal amount of $2,295,464 issued to the M. Lee Pearce 1998 Irrevocable Trust (incorporated by reference to Exhibit 10.25 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2003 as filed with the SEC on March 22, 2004).                                                                   |

----

Index

| 10.19  | Promissory Note dated March 11, 2004, in the principal amount of $93,022 issued to M. Lee Pearce, M.D.(incorporated by reference to Exhibit 10.26 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2003 as filed with the SEC on March 22, 2004).                                                                                                         |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.20  | Promissory Note dated March 12, 2004, in the principal amount of $38,000 issued to M. Lee Pearce M.D. (incorporated by reference to Exhibit 10.27 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2003 as filed with the SEC on March 22, 2004).                                                                                                         |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.21  | Promissory Note dated April 14, 2004, in the principal amount of $126,000 issued to M. Lee Pearce, M.D.(incorporated by reference to Exhibit 10.28  in the Company’s Quarterly Report on Form 10-QSB for the quarter ended March 31, 2004, as filed with the SEC on May 12, 2004).                                                                                                  |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.22  | Promissory Note dated July 6, 2004, in the principal amount of $23,000 issued to M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.1 in the Company’s Quarterly Report on Form 10-QSB for the quarter ended June 30, 2004, as filed with the SEC on August 13, 2004).                                                                                                              |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.23  | Promissory Note dated August 6, 2004, in the principal amount of $35,000 issued to M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.1 in the Company’s Quarterly Report on Form 10-QSB for the quarter ended September 30, 2004, as filed with the SEC on November 15, 2004).                                                                                                     |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.24  | Promissory Note dated October 11, 2004, in the principal amount of $140,000 issued to M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.2 in the Company’s Quarterly Report on Form 10-QSB for the quarter ended September 30, 2004, as filed with the SEC on November 15, 2004).                                                                                                  |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.25  | Promissory Note dated November 18, 2004, in the principal amount of $29,000 issued to M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.32 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2004, as filed with the SEC on March 30, 2005).                                                                                                    |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.26  | Promissory Note dated December 2, 2004, in the principal amount of $35,000 issued to M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.33 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2004, as filed with the SEC on March 30, 2005).                                                                                                     |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.27  | Stock Exchange and Merger Agreement dated as of January 7, 2005 among Healthology, Inc., iVillage, Inc., Virtue Acquisition Corporation and certain stockholders of Healthology, Inc., including the Company (incorporated by reference to Exhibit 10.34 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2004, as filed with the SEC on March 30, 2005). |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.28  | Stock Purchase Agreement dated as of January 7, 2005 between the Company and Steven Haimowitz (incorporated by reference to Exhibit 10.35 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2004, as filed with the SEC on March 30, 2005).                                                                                                                |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.29  | Exchange and Termination Agreement dated March 17, 2006, effective as of March 15, 2006, between Le@P Technology, Inc. and the M. Lee Pearce 2005 Irrevocable Trust (incorporated by reference to Exhibit 10.1 in the Company’s Current Report on Form 8-K as filed with the SEC on March 21, 2006).                                                                                          |
|   |                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.30  | Fairness Opinion dated March 15, 2006 issued by Stenton Leigh Valuation Group, Inc. on March 16, 2006 (incorporated by reference to Exhibit 10.2 in the Company’s Current Report on Form 8-K as filed with the SEC on March 21, 2006).                                                                                                                                                        |

----

Index

| 10.31  | Promissory Note dated March 17, 2006 in the principal amount of $562,500 executed by Parkson Property, LLC in favor of Bay Colony Associates, Ltd. (incorporated by reference to Exhibit 10.3 in the Company’s Current Report on Form 8-K as filed with the SEC on March 21, 2006).          |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                               |
| 10.32  | Employment Agreement, dated as of November 1, 2006 by and between Le@P Technology, Inc. and Dr. Donald J. Ciappenelli (incorporated by reference to Exhibit 10.1 in the Company’s Current Report on Form 8-K as filed with the SEC on November 3, 2006)                                      |
|   |                                                                                                                                                                                                                                                                                               |
| 10.33  | Employment Agreement, dated as of March 5, 2007 by and between Le@P Technology, Inc. and Dr. Howard Benjamin. (incorporated by reference to Exhibit 10.33 in the Company’s Form 10 KSB as filed with the SEC on March 30, 2007)                                                              |
|   |                                                                                                                                                                                                                                                                                               |
| 10.34  | Renewal Promissory Note dated as of October 24, 2007 in the principal amount of $562,500 executed by Parkson, LLC in favor of Bay Colony Associates, Ltd. (incorporated by reference to Exhibit 10.1 in the Company’s Current Report on Form 8-K as filed with the SEC on October 25, 2007). |
|   |                                                                                                                                                                                                                                                                                               |
| 10.35  | Promissory Note dated June 15, 2009 in the principal amount of $25,000 in favor of M. Lee Pearce Living Trust (incorporated by reference to Exhibit 10.27 in the Company’s Form 10 Q as filed on August 22, 2009).                                                                           |
|   |                                                                                                                                                                                                                                                                                               |
| 10.36  | Promissory Note dated September 1, 2009 in the principal amount of $55,000 in favor of M. Lee Pearce Living Trust (incorporated by reference to Exhibit 10.28 in the Company’s Form 10 Q as filed on November 12, 2009).                                                                     |
|   |                                                                                                                                                                                                                                                                                               |
| 21     | Subsidiaries of the Registrant.                                                                                                                                                                                                                                                                    |
|   |                                                                                                                                                                                                                                                                                               |
| 31.1   | Certification of the Acting Principal Financial Officer  to Section 302 of the Sarbanes-Oxley Act of 2002.*                                                                                                                                                                              |
|   |                                                                                                                                                                                                                                                                                               |
| 31.2   | Certification of the Acting Principal Financial Officer Report pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                                                                                                                                          |
|   |                                                                                                                                                                                                                                                                                               |
| 32     | Certification  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                                                                                                                                                |

|   | (b) | Filed herewith |
|--------|-----|----------------|

| 21 | Subsidiaries of the Registrant. |
|----|---------------------------------|

| 31.1 | Certification of the Acting Principal Financial Officer  to Section 302 of the Sarbanes-Oxley Act of 2002. |
|------|----------------------------------------------------------------------------------------------------------------------|

| 31.2 | Certification of the Acting Principal Financial Officer Report pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|------|---------------------------------------------------------------------------------------------------------------------------|

| 32 | Certification  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|----|-------------------------------------------------------------------------------------|

----

Index

|   | LE@P TECHNOLOGY, INC. |
|--------|-----------------------|
|   |                  |   |
|   | By:                   | /s/Timothy Lincoln |
|   |                  | Timothy Lincoln, |
|   |                  | Acting Principal Executive Officer |
|   |                  |   |
|   |                  |   |
|   | By:                   | /s/ Mary E. Thomas |
|   |                  | Mary E. Thomas, |
|   |                  | Acting Principal Financial Officer |

| SIGNATURE               | TITLE                                           | DATE           |
|-------------------------|-------------------------------------------------|----------------|
|                    |                                            |           |
| /s/ Timothy Lincoln     | Acting Principal Executive Officer and Director | March 29, 2010 |
| Timothy Lincoln         |                                            |           |
|                    |                                            |           |
| /s/ Mary E. Thomas      | Acting Principal Financial Officer and Director | March 29, 2010 |
| Mary E. Thomas          |                                            |           |
|                    |                                            |           |
| /s/ Jerome Fields, M.D. | Director                                        | March 29, 2010 |
| Jerome Fields, M.D.     |                                            |           |

----

Index

| Le@P Technology, Inc. and Subsidiaries                                                               | PAGE             |
|------------------------------------------------------------------------------------------------------|------------------|
|                                                                                                 |             |
| Report of Independent Registered Public Accounting Firm                                              | F-2              |
|                                                                                                 |             |
| Consolidated Balance Sheets as of December 31, 2009 and 2008                                         | F-3, F-4         |
|                                                                                                 |             |
| Consolidated Statements of Operations for the years ended December 31, 2009 and 2008                 | F-5              |
|                                                                                                 |             |
| Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2009 and 2008 | F-6              |
|                                                                                                 |             |
| Consolidated Statements of Cash Flows for the years ended December 31, 2009 and 2008                 | F-7              |
|                                                                                                 |             |
| Notes to Consolidated Financial Statements                                                           | F-8 – F-16 |

----

Index

----

Index

|                                      |   | December 31, |    |
|-------------------------------------------|--------|--------------|---------|
|                                      |   | 2009         |    |   | 2008 |   |
| Assets                                    |   |         |    |   |   |   |
| Current assets:                           |   |         |    |   |   |   |
| Cash and cash equivalents                 |   | $            | 15,090  |   |   | $ | 359,032 |   |
| Accounts receivable                       |   |         | 3,706   |   |   |   | 478 |   |
| Prepaid expenses and other current assets |   |         | 7,845   |   |   |   | 8,087 |   |
| Total current assets                      |   |         | 26,641  |   |   |   | 367,597 |   |
|                                      |   |         |    |   |   |   |   |   |
|                                      |   |         |    |   |   |   |   |   |
| Property and equipment, net               |   |         | 512,837 |   |   |   | 514,196 |   |
| Other assets                              |   |         | 19,185  |   |   |   | 31,842 |   |
| Total assets                              |   | $            | 558,663 |   |   | $ | 913,635 |   |

----

Index

|                                                                                                                                                                |   | December 31, |        |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------|-------------|
|                                                                                                                                                                |   | 2009         |        |   | 2008 |   |
| Liabilities and stockholders’ equity                                                                                                                          |   |         |        |   |   |   |
| Current liabilities:                                                                                                                                                |   |         |        |   |   |   |
| Accounts payable                                                                                                                                                    |   | $            | 12,542      |   |   | $ | 11,288 |   |
| Accrued professional fees                                                                                                                                           |   |         | 55,250      |   |   |   | 58,204 |   |
| Accrued compensation and related liabilities                                                                                                                        |   |         | 5,460       |   |   |   | 33,889 |   |
| Total current liabilities                                                                                                                                           |   |         | 73,252      |   |   |   | 103,381 |   |
|                                                                                                                                                                |   |         |        |   |   |   |   |   |
| Long-term notes payable to related party                                                                                                                            |   |         | 642,500     |   |   |   | 562,500 |   |
|                                                                                                                                                                |   |         |        |   |   |   |   |   |
| Long-term accrued interest payable to related party                                                                                                                 |   |         | 150,449     |   |   |   | 110,034 |   |
|                                                                                                                                                                |   |         |        |   |   |   |   |   |
| Total liabilities                                                                                                                                                   |   |         | 866,201     |   |   |   | 775,915 |   |
|                                                                                                                                                                |   |         |        |   |   |   |   |   |
| Commitments and contingencies                                                                                                                                       |   |         |        |   |   |   |   |   |
|                                                                                                                                                                |   |         |        |   |   |   |   |   |
| Stockholders’ equity (deficiency):                                                                                                                            |   |         |        |   |   |   |   |   |
| Preferred stock, par value $0.001 per share.  Authorized 25,000,000 shares.  Issued and outstanding 2,170 shares at December 31, 2009 and 2008. |   |         | 2,170,000   |   |   |   | 2,170,000 |   |
| Class A common stock, $0.01 par value 149,975,000 shares authorized and 65,280,759 shares issued at December 31, 2009 and December 31, 2008.                        |   |         | 652,808     |   |   |   | 652,808 |   |
| Class B common stock, $0.01 par value per share.  Authorized, issued and outstanding 25,000 shares at December 31, 2009 and 2008.                         |   |         | 250         |   |   |   | 250 |   |
| Additional paid-in capital                                                                                                                                          |   |         | 35,981,387  |   |   |   | 36,033,115 |   |
| Accumulated deficit                                                                                                                                                 |   |         | (39,062,523 | ) |   |   | (38,668,993 | ) |
| Treasury stock, at cost, 84,850 shares at December 31, 2009 and 2008                                                                                                |   |         | (49,460     | ) |   |   | (49,460 | ) |
|                                                                                                                                                                |   |         |        |   |   |   |   |   |
| Total stockholders’ equity  (deficiency)                                                                                                            |   |         | (307,538    | ) |   |   | 137,720 |   |
| Total liabilities and stockholders’ equity (deficiency)                                                                                                       |   | $            | 558,663     |   |   | $ | 913,635 |   |

----

Index

|                                               |   | Years ended December 31, |       |
|----------------------------------------------------|--------|--------------------------|------------|
|                                               |   | 2009                     |       |   | 2008 |   |
| Revenue                                            |   | $                        | –    |   |   | $ | – |   |
|                                               |   |                     |       |   |   |   |   |   |
| General and administrative expenses:               |   |                     |       |   |   |   |   |   |
| Salaries and benefits                              |   |                     | 184,204    |   |   |   | 831,857 |   |
| Share-based compensation expense                   |   |                     | (51,728    | ) |   |   | (69,498 | ) |
| Professional fees                                  |   |                     | 117,095    |   |   |   | 428,914 |   |
| Other                                              |   |                     | 148,722    |   |   |   | 203,375 |   |
|                                               |   |                     |       |   |   |   |   |   |
| Total general and administrative expenses          |   |                     | 398,293    |   |   |   | 1,394,648 |   |
|                                               |   |                     |       |   |   |   |   |   |
| Other income (expenses):                           |   |                     |       |   |   |   |   |   |
| Interest expense                                   |   |                     | (40,415    | ) |   |   | (39,483 | ) |
| Interest income                                    |   |                     | 1,778      |   |   |   | 23,524 |   |
| Rental income                                      |   |                     | 43,400     |   |   |   | 26,550 |   |
| Other income                                       |   |                     | -          |   |   |   | 2,332 |   |
|                                               |   |                     |       |   |   |   |   |   |
| Total other income (expenses)                      |   |                     | 4,763      |   |   |   | 12,923 |   |
|                                               |   |                     |       |   |   |   |   |   |
| Loss before income taxes                           |   |                     | (393,530   | ) |   |   | (1,381,725 | ) |
|                                               |   |                     |       |   |   |   |   |   |
| Provision for income taxes                         |   |                     | -          |   |   |   | - |   |
|                                               |   |                     |       |   |   |   |   |   |
| Net loss                                           |   |                     | (393,530   | ) |   |   | (1,381,725 | ) |
|                                               |   |                     |       |   |   |   |   |   |
| Dividends undeclared on cumulative preferred stock |   |                     | 217,000    |   |   |   | 217,000 |   |
|                                               |   |                     |       |   |   |   |   |   |
| Net loss attributable to common stockholders       |   | $                        | (610,530   | ) |   |   | (1,598,7255 | ) |
|                                               |   |                     |       |   |   |   |   |   |
| Basic and diluted net loss per share:              |   |                     |       |   |   |   |   |   |
| Net loss per common share:                         |   | $                        | (0.01      | ) |   | $ | (0.02 | ) |
| Net loss attributable to common stockholders       |   | $                        | (0.01      | ) |   | $ | (0.02 | ) |
|                                               |   |                     |       |   |   |   |   |   |
|                                               |   |                     |       |   |   |   |   |   |
| Basic weighted average shares outstanding          |   |                     | 65,305,759 |   |   |   | 65,305,759 |   |
| Diluted weighted average shares outstanding        |   |                     | 65,305,759 |   |   |   | 65,305,759 |   |

----

Index

|                                                          |   | Preferred Stock |   |   | Class A and Class BCommon Stock |   |      | Additional Paid-in |   |   | Accumulated    |   |   | Treasury |    |   | Total   |   |
|---------------------------------------------------------------|--------|-----------------|--------|--------|-----------------------------------------------------|--------|-----------|--------------------|--------|--------|----------------|--------|--------|----------|---------|--------|---------|--------|
|                                                          |   | Shares          |   |   | Amount                                              |   |      | Shares             |   |   | Par Value |   |   | Capital  |    |   | Deficit |   |   | Stock |   |   |   |   |
| Balance at December 31, 2007                                  |   |            | 2,170  |   |                                                | $      | 2,170,000 |               |   |   | 65,305,759     |   |   | $        | 653,058 |   |    | $      | 36,102,613 |   |   | $ | (37,287,268 | ) |   | $ | (49,460 | ) |   | $ | 1,588,943 |   |
|                                                          |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                                      |   |            | -      |   |                                                |   | -         |               |   |   | -              |   |   |     | -       |   |    |   | - |   |   |   | (1,381,725 | ) |   |   | - |   |   |   | (1,381,725 | ) |
|                                                          |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Share-based compensation on stock options                     |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   | 164,322 |   |   |   |   |   |   |   |   |   |   |   | 164,322 |   |
|                                                          |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Forfeited stock options reduction to share-based compensation |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   | (233,820 | ) |   |   |   |   |   |   |   |   |   |   | (233,820 | ) |
|                                                          |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance at December 31, 2008                                  |   |            | 2,170  |   |                                                |   | 2,170,000 |               |   |   | 65,305,759     |   |   |     | 653,058 |   |    |   | 36,033,115 |   |   |   | (38,668,993 | ) |   |   | (49,460 | ) |   |   | 137,720 |   |
|                                                          |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                                      |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   |   |   |   |   | (393,530 | ) |   |   |   |   |   |   | (393,540 | ) |
|                                                          |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Forfeited stock options reduction to share-based compensation |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   | (51,728 | ) |   |   |   |   |   |   |   |   |   |   | (51,728 | ) |
|                                                          |   |            |   |   |                                                |   |      |               |   |   |           |   |   |     |    |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance at December 31, 2009                                  |   |            | 2,170  |   |                                                | $      | 2,170,000 |               |   |   | 65,305,759     |   |   | $        | 653,058 |   |    | $      | 35,981,387 |   |   | $ | (39,062,523 | ) |   | $ | (49,460 | ) |   | $ | (307,538 | ) |

----

Index

|                                                                        |   | Years ended December 31, |     |
|-----------------------------------------------------------------------------|--------|--------------------------|----------|
|                                                                        |   | 2009                     |     |   | 2008 |   |
| Cash flows from operating activities:                                       |   |                     |     |   |   |   |
| Net loss                                                                    |   | $                        | (393,530 | ) |   | $ | (1,381,725 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: |   |                     |     |   |   |   |   |   |
| Depreciation                                                                |   |                     | 1,359    |   |   |   | 1,359 |   |
| Share-based compensation expense                                            |   |                     | (51,728  | ) |   |   | (69,498 | ) |
| Changes in operating assets and liabilities:                                |   |                     |     |   |   |   |   |   |
| Accounts receivable                                                         |   |                     | (3,228   | ) |   |   | 6,361 |   |
| Prepaid expenses and other current assets                                   |   |                     | 242      |   |   |   | (591 | ) |
| Other assets                                                                |   |                     | 12,657   |   |   |   | (8,000 | ) |
| Accounts payable and other accrued expenses                                 |   |                     | 1,253    |   |   |   | (631 | ) |
| Accrued professional fees                                                   |   |                     | (2,954   | ) |   |   | 8,028 |   |
| Accrued compensation and related liabilities                                |   |                     | (28,429  | ) |   |   | (23,984 | ) |
| Accrued interest payable to related party                                   |   |                     | 40,416   |   |   |   | 39,483 |   |
| Net cash used in operating activities                                       |   |                     | (423,942 | ) |   |   | (1,429,198 | ) |
|                                                                        |   |                     |     |   |   |   |   |   |
| Cash flows from investing activities:                                       |   |                     |     |   |   |   |   |   |
| Net cash provided by investing activities                                   |   |                     | -        |   |   |   | - |   |
|                                                                        |   |                     |     |   |   |   |   |   |
| Cash flows from financing activities:                                       |   |                     |     |   |   |   |   |   |
| Proceeds from related party                                                 |   |                     | 80,000   |   |   |   | - |   |
| Net cash provided by financing activities                                   |   |                     | 80,000   |   |   |   | - |   |
|                                                                        |   |                     |     |   |   |   |   |   |
|                                                                        |   |                     |     |   |   |   |   |   |
| Net decrease in cash and cash equivalents                                   |   |                     | (343,942 | ) |   |   | (1,429,198 | ) |
| Cash and cash equivalents at beginning of year                              |   |                     | 359,032  |   |   |   | 1,788,230 |   |
| Cash and cash equivalents at end of year                                    |   | $                        | 15,090   |   |   | $ | 359,032 |   |

----

Index

----

Index

----

Index

----

Index

----

Index

----

Index

|                          |   | December 31, |    |
|-------------------------------|--------|--------------|---------|
|                          |   | 2009         |    |   | 2008 |   |
| Land                          |   | $            | 510,000 |   |   | $ | 510,000 |   |
| Leasehold improvements        |   |         | 17,842  |   |   |   | 17,842 |   |
| Equipment and software        |   |         | 16,340  |   |   |   | 16,340 |   |
| Furniture and fixtures        |   |         | 59,433  |   |   |   | 59,433 |   |
|                          |   |         | 603,615 |   |   |   | 603,615 |   |
| Less accumulated depreciation |   |         | 90,778  |   |   |   | 89,419 |   |
|                          |   | $            | 512,837 |   |   | $ | 514,196 |   |

----

Index

| Dividend yield          |   |          | 0      | %      |          |   | 0    | % |
|-------------------------|--------|---------------|--------|--------|---------------|--------|------|---|
| Expected volatility     |   |          | 134    | %      |          |   | 134  | % |
| Risk free interest rate |   |          | 4.56   | %      |          |   | 4.56 | % |
| Expected life           |   | 10 years |   |   | 10 years |   |

----

Index

|                              |   | 2009   |       |   | 2008                            |   |
|-----------------------------------|--------|--------|------------|--------|---------------------------------|--------|
|                              |   | Shares |       |   | Weighted Average Exercise Price |   |   | Weighted Average Remaining Life |   |   | Shares |   |   | Weighted Average Exercise Price |   |   | Weighted Average Remaining Life |   |
| Outstanding at beginning of year  |   |   | 3,055,596  |   |                            | $      | 0.18 |   |   |   | 7.8 |   |   |   | 3,511,088 |   |   | $ | 0.26 |   |   |   | 8.7 |   |
| Options granted                   |   |   | -          |   |                            |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Options expired or forfeited      |   |   | (3,003,096 | )      |                            | $      | 0.14 |   |   |   | 7.0 |   |   |   | (455,492 | ) |   | $ | 0.80 |   |   |   | 7.9 |   |
| Outstanding at end of year        |   |   | 52,500     |   |                            | $      | 3.00 |   |   |   | .2 |   |   |   | 3,055,596 |   |   | $ | 0.18 |   |   |   | 7.8 |   |
| Options exercisable at year-end   |   |   | 52,500     |   |                            | $      | 3.00 |   |   |   | .2 |   |   |   | 2,130,480 |   |   | $ | 0.26 |   |   |   | 7.8 |   |
| Shares available for future grant |   |   | 10,047,500 |   |                            |   |   |   |   |   |   |   |   |   | 7,044,404 |   |   |   |   |   |   |   |   |   |

| Exercise Price |   |   | Options Outstanding |   |   | Weighted Average Remaining Life |   |   | Options Exercisable |   |
|----------------|--------|--------|---------------------|--------|--------|---------------------------------|--------|--------|---------------------|--------|
| $              | 3.00   |   |                |   | 52,500 |                            |   |   | .2                  |   |   |   | 52,500 |   |
|           |   |   |                |   | 52,500 |                            |   |   |                |   |   |   | 52,500 |   |

----

Index

|                             |   | For the Years ended December 31, |      |
|----------------------------------|--------|----------------------------------|-----------|
|                             |   | 2009                             |      |   | 2008 |   |
| Deferred tax assets:             |   |                             |      |   |   |   |
| Net operating loss carryforwards |   | $                                | 4,100,290 |   |   | $ | 3,935,533 |   |
| Accruals                         |   |                             | 58,504    |   |   |   | 56,106 |   |
| Stock –based compensation  |   |                             | 151,480   |   |   |   | 170,945 |   |
| Other                            |   |                             | -         |   |   |   | 4,723 |   |
| Deferred tax assets              |   |                             | 4,314,909 |   |   |   | 4,167,307 |   |
| Less valuation allowance         |   |                             | 4,314,909 |   |   |   | (4,167,307 | ) |
| Net deferred tax assets          |   | $                                | –   |   |   | $ | – |   |

|                                       |   | For the Years ended December 31, |   |
|--------------------------------------------|--------|----------------------------------|--------|
|                                       |   | 2009                             |   |   | 2008 |   |
| U.S. Federal Statutory rate                |   |                             | 34.00  | % |   |   | 34.00 | % |
| State income taxes, net of federal benefit |   |                             | 3.63   |   |   |   | 3.63 |   |
| Change in valuation allowance              |   |                             | (37.63 | ) |   |   | (37.63 | ) |
|                                       |   |                             | 0.00   | % |   |   | 0.00 | % |

| Description                            |   | Balance at Beginning of Period |      |   | Charged to Costs and Expenses |   |    | Write-off’s |   |   | Other Changes |   |   | Balance at End of Period |   |
|----------------------------------------|--------|--------------------------------|-----------|--------|-------------------------------|--------|---------|-------------------|--------|--------|---------------|--------|--------|--------------------------|--------|
| Deferred tax asset valuation allowance |   |                           |      |   |                          |   |    |              |   |   |          |   |   |                     |   |
|                                   |   |                           |      |   |                          |   |    |              |   |   |          |   |   |                     |   |
| Year ended December 31, 2009           |   | $                              | 4,167,307 |   |                          |   | 147,602 |              |   |   | -             |   |   |                     | -      |   |   | $ | 4,314,909 |   |
| Year ended December 31, 2008           |   | $                              | 3,605,424 |   |                          |   | 561,883 |              |   |   | -             |   |   |                     | -      |   |   | $ | 4,167,307 |   |

----

Index

----